Convalescent Plasma Therapy on Critically-ill Novel Coronavirus (COVID-19) Patients
Clinical trial NCT04441424 · COMPLETED
Trial details
- NCT number
- NCT04441424
- Sponsor
- Alkarkh Health Directorate-Baghdad
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-03
- Primary completion
- 2020-06-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.